DV
Dividend Vision

KBLB — Kraig Biocraft Labs

Kraig Biocraft Labs (KBLB)

Total return is 80.0% over the past 18.5 years, 634.5 points behind SPY at 714.5%. Its deepest 1-year drawdown was 45.2%.

KBLB is an equity fund focused on biotech and life sciences holdings, launched in 2008. The fund does not currently distribute dividends to shareholders, making it unsuitable for income-focused investors seeking regular payouts. This fund may appeal to growth-oriented investors interested in exposure to the biotechnology sector, though potential investors should note that limited information is available regarding its specific holdings, expense ratio, and current asset base.

KBLB key facts

Asset type
Stock
Asset class
Equity
Inception date
02/29/2008
Distribution frequency
None
Last close
$0.09
Market cap
$97,948,352
Average volume
808000.0
Beta
1.583
Payout ratio
0.0
P/E ratio
0.0
Forward P/E
0.0
EPS
$0.00